Home Compliance Eli Lilly Accused of Defrauding Government in $60 Million Qui Tam Suit ComplianceExpert OpinionFCANews Eli Lilly Accused of Defrauding Government in $60 Million Qui Tam Suit August 2, 2022 42 Share FacebookLinkedinTwitter Michael Vi | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Scope and Impact of the FTC’s Non-Compete Rule for Employers Cyber Largest Cyberattack on U.S. Healthcare Industry Might Endanger Millions of Veterans Compliance CISA Unveils Final Self-Attestation Form for Software Producers Bidding on Federal Contracts